Target Information
Target General Information | Top | |||||
---|---|---|---|---|---|---|
Target ID |
T20593
|
|||||
Target Name |
Tumor-associated glycan antigen (TAGA)
|
|||||
Gene Name |
NOUNIPROTAC
|
|||||
Target Type |
Clinical trial target
|
[1] | ||||
Disease | [+] 1 Target-related Diseases | + | ||||
1 | Solid tumour/cancer [ICD-11: 2A00-2F9Z] | |||||
UniProt ID |
Drugs and Modes of Action | Top | |||||
---|---|---|---|---|---|---|
Clinical Trial Drug(s) | [+] 1 Clinical Trial Drugs | + | ||||
1 | GNX102 | Drug Info | Phase 1 | Solid tumour/cancer | [2] |
References | Top | |||||
---|---|---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of GlycoNex. | |||||
REF 2 | ClinicalTrials.gov (NCT04250597) Study of GNX102 in Patients With Advanced Solid Tumors. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.